Evidence map›Paper›PMID 30112409›Full record

ReviewBioMed research international2018

Risks in Surrogacy Considering the Embryo: From the Preimplantation to the Gestational and Neonatal Period.

M Simopoulou, K Sfakianoudis, P Tsioulou, A Rapani, G Anifandis, A Pantou, S Bolaris, P Bakas, E Deligeoroglou, K Pantos and 1 more

Abstract readReview
In one paragraph

Review in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Commercial Surrogacy: An Overview.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2022
    Review
  4. Article
  5. Article
  6. The Growing Trend of Surrogacy in Nigeria: Implications for Quality Newborn Care: A Case Report.Nigerian medical journal : journal of the Nigeria Medical Association
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

M SimopoulouDepartment of Physiology, Medical School, National and Kapodistrian University of Athens, Greece.ORCID 0000-0002-1000-9100
K SfakianoudisCentre for Human Reproduction, Genesis Athens Clinic, Greece.
P TsioulouDepartment of Physiology, Medical School, National and Kapodistrian University of Athens, Greece.ORCID 0000-0002-3535-8227
A RapaniDepartment of Physiology, Medical School, National and Kapodistrian University of Athens, Greece.ORCID 0000-0001-7636-5848
G AnifandisDepartment of Histology and Embryology, Faculty of Medicine, University of Thessaly, Greece.ORCID 0000-0001-8655-540X
A PantouCentre for Human Reproduction, Genesis Athens Clinic, Greece.
S BolarisAssisted Conception Unit, General-Maternity District Hospital "Elena Venizelou", Greece.
P BakasAssisted Conception Unit, 2 Department of Obstetrics and Gynecology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
E DeligeoroglouAssisted Conception Unit, 2 Department of Obstetrics and Gynecology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
K PantosCentre for Human Reproduction, Genesis Athens Clinic, Greece.
M KoutsilierisDepartment of Physiology, Medical School, National and Kapodistrian University of Athens, Greece.ORCID 0000-0002-3340-9916

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surrogacy is an assisted reproduction-based approach in which the intended parents assign the gestation and birth to another woman called the surrogate mother. The drivers of surrogacy refer largely to infertility, medical conditions, same-sex couples' parenting, and cases of diversity regarding sexual identity and orientation. Surrogacy consists of a valid option for a variety of conditions or circumstances ranging from medical to social reasons. However, surrogacy may be associated with risks during the preimplantation, prenatal, and neonatal period. It became obvious during the exhaustive literature research that data on surrogacy and its association with factors specific to the IVF practice and the options available were not fully represented. Could it be that surrogacy management adds another level of complexity to the process from the ovarian stimulation, the subsequent IVF cycle, and the techniques employed within the IVF and the Genetic Laboratory to the fetal, perinatal, and neonatal period? This work emphasizes the risks associated with surrogacy with respect to the preimplantation embryo, the fetus, and the infant. Moreover, it further calls for larger studies reporting on surrogacy and comparing the surrogate management to that of the routine IVF patient in order to avoid suboptimal management of a surrogate cycle. This is of particular importance in light of the fact that the surrogate cycle may include not only the surrogate but also the egg donor, sperm donor, and the commissioning couple or single person.

Indexed as

Gestational CarriersInfertilityPrenatal CareFemaleHumansInfantParturitionPregnancyRisk

Identifiers

PMID30112409
PMCPMC6077588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.